Nagashima Kazunori, Irisawa Atsushi, Kashima Ken, Sakuma Fumi, Minaguchi Takahito, Yamamiya Akira, Yamabe Akane, Hoshi Koki, Tominaga Keiichi, Iijima Makoto, Goda Kenichi
Department of Gastroenterology, Dokkyo Medical University School of Medcine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
Healthcare (Basel). 2022 Jun 26;10(7):1193. doi: 10.3390/healthcare10071193.
Red color sign-positive (RC-positive) esophageal varices present a high bleeding risk, necessitating prophylactic treatment. Among RC-positive esophageal varices, those classified morphologically as small straight varices (Form level 1: F1) are difficult to treat. Moreover, the appropriate time for therapeutic intervention remains undefined. This study assessed the bleeding risk in RC-positive F1 esophageal varices. After extracting 541 cases of F1 esophageal varices diagnosed during 1 January 2012−29 February 2020, 76 cases of RC-positive F1 esophageal varices were divided into two groups in terms of treatment intervention at diagnosis: 49 cases with (treatment group) and 27 cases without (follow-up group). We assessed the bleeding rates, bleeding-associated factors, and early-bleeding-associated factors. The treatment group’s bleeding rate was 10% (5/49). The follow-up group’s bleeding rate was 78% (21/24). The subsequent bleeding rate was low in the treatment group (p < 0.001). The median period of sustained absence of bleeding was longer in the treatment group than in the follow-up group (1156 [274−1582] days vs. 105 [1−336] days; p < 0.001). In the follow-up group, a significant number of bleedings had varices that included a hematocystic spot (HCS) as RC or combined with RC (p = 0.017). Early bleeding occurred often in varices that included HCS or combined with RC (p = 0.024). Red wale marking (RWM) only was not a factor of early bleeding (p = 0.012). In conclusion, RC-positive varices should be treated even as F1 varices. Patients with RWM only show the possibility of not accepting early treatment intervention. A fast response is crucially important in HCS cases because of its associated bleeding and early bleeding.
红色征阳性(RC阳性)食管静脉曲张具有较高的出血风险,需要进行预防性治疗。在RC阳性食管静脉曲张中,形态学上分类为小直静脉曲张(形态分级1级:F1)的静脉曲张难以治疗。此外,治疗干预的合适时机仍不明确。本研究评估了RC阳性F1食管静脉曲张的出血风险。在提取了2012年1月1日至2020年2月29日期间诊断出的541例F1食管静脉曲张病例后,将76例RC阳性F1食管静脉曲张根据诊断时的治疗干预情况分为两组:49例接受治疗的(治疗组)和27例未接受治疗的(随访组)。我们评估了出血率、出血相关因素和早期出血相关因素。治疗组的出血率为10%(5/49)。随访组的出血率为78%(21/24)。治疗组随后的出血率较低(p<0.001)。治疗组持续无出血的中位时间比随访组长(1156[274 - 1582]天对105[1 - 336]天;p<0.001)。在随访组中,大量出血的静脉曲张有血囊肿斑(HCS)作为RC或与RC合并(p = 0.017)。早期出血常发生在有HCS或与RC合并的静脉曲张中(p = 0.024)。仅有红色条纹征(RWM)不是早期出血的因素(p = 0.012)。总之,即使是F1级静脉曲张,RC阳性静脉曲张也应接受治疗。仅有RWM的患者显示出不接受早期治疗干预的可能性。由于HCS相关的出血和早期出血,在HCS病例中快速反应至关重要。